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metabolites in different water matrices†
Garyfalia A. Zoumpouli, abc Fernanda Siqueira Souza,bcde Bruce Petrie, cfg
Liliana Amaral Féris,d Barbara Kasprzyk-Hordern cf and Jannis Wenk *bc
The ozonation of 90 chemically diverse organic micropollutants (OMPs) including four classes of illicit
drugs and their metabolites was studied in pure buffered water, tap water and wastewater effluent at three
specific ozone doses and three pH levels. The second order rate constants for the reaction of 40 OMPs
with ozone were known and span across 8 orders of magnitude, from below 1 M−1 s−1 to above 107 M−1 s−1.
47 of the tested OMPs were removed to at least 90% at the highest specific ozone dose of 0.3 mM O3 per
mM C at pH 7. However, most illicit drugs, including cocainics, amphetamines and ecstasy-group
compounds, were ozone-resistant due to their lack of ozone-reactive functional groups. Exceptions
included some opioids and the cocaine biomarker anhydroecgonine methylester which contain olefinic
bonds and/or activated benzene rings. Different removal trends at different pH for OMPs were due to the
combined effect of target compound speciation and ozone stability, leading to elimination of less than
70% for all OMPs at pH 11. In both tap water and wastewater effluent scavenging by matrix components
led to lower ozone exposure compared to pure buffered water and consequently lower removal of OMPs.
This multi-compound ozonation study utilised liquid chromatography-mass spectrometry to provide a
large dataset on the removal of environmentally relevant OMPs, including those of interest for drinking
water regulations. Besides including pharmaceutically active compounds that have not been studied with
ozone before (e.g. gliclazide, anhydroecgonine methylester, quetiapine, 6-monoacetylmorphine), this study
simultaneously shows ozonation data for a wide range of illicit drugs.
1. Introduction
Many different organic micropollutants (OMPs) including
pharmaceuticals, personal care products, hormones and their
transformation products can be found at trace concentrations
in surface water, groundwater and finished drinking water.1–4
OMPs may reach drinking water resources through numerous
routes, with their main sources being the discharge of
wastewater effluent and diffuse pollution, such as
agricultural and urban runoff.5,6 OMPs have raised scientific
and public concern regarding their impact on the
environment and on human health, including short-term
and long-term toxicity, endocrine disruption, antibiotic
resistance of microorganisms and accumulation in soils,
plants and animals.7,8 A group of OMPs of particular interest
are illicit drugs and their metabolites,9–12 due to biological
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Water impact
Ozonation is a promising technology for the removal of organic micropollutants from water. Here, ozonation results for 90 chemically diverse
micropollutants including illicit drugs are reported and interpreted based on compound chemical structure. The study provides a valuable ozonation
database for a large variety of micropollutants with specific focus on occurrence and ozonation of illicit drugs in drinking water.
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activity and largely unknown effects on the environment and
on water quality.13,14
Ozonation is among the most effective methods for the
abatement of OMPs in full-scale water treatment applications.15
Ozone is a strong oxidant which reacts with organic compounds
in water either directly, or indirectly through free radicals
produced from ozone decomposition.16 The ozonation of single
compounds has been extensively studied in terms of
degradation, reaction kinetics and identification of
transformation products.17–20 Analytical advancements have also
enabled the investigation of the simultaneous ozonation of
mixtures of OMPs. Multi-component ozonation studies have
been performed at lab-, pilot- and full-scale and have included a
wide range of compounds.21–25 However, the ozonation of some
classes of OMPs, including illicit drugs and their metabolites,
remains less conclusively studied.11,26–28
The reactivity of organic compounds with ozone depends
on their chemical structure, with second order rate constants
reaching across several orders of magnitude.29 Kinetic
parameters of ozonation reactions can be determined
experimentally or calculated through QSAR (quantitative
structure–activity relationship) models.30 In complex water
matrices, such as surface water, the properties of the matrix
affect the stability of dissolved ozone, while matrix
components act as oxidant scavengers, increasing the
required ozone dose for a desired extent of OMP abatement.
Therefore, the abatement of OMPs by ozonation can be
related to kinetic parameters, operational parameters (e.g.
ozone dose, temperature) and water quality parameters (e.g.
organic carbon concentration, pH, alkalinity).31,32
The aim of this study was to gain insights into the
simultaneous ozonation of 90 chemically diverse OMPs. The
selection of the compounds was based on existing and proposed
EU legislation, UK prescription data, metabolism and excretion
from the human body, known environmental occurrence,
persistence during wastewater treatment and toxicity to aquatic
organisms.33 Ozonation experiments were conducted in three
different water matrices (pure buffered water, tap water and
wastewater effluent), at different ozone doses and pH levels. In
contrast to the majority of previous ozonation studies, several
illicit drugs and illicit drug metabolites were investigated. For
some compounds, the reactivity with ozone in water is
investigated for the first time, including the diabetes drug
gliclazide, the cocaine biomarker anhydroecgonine methylester,
the antipsychotic drug quetiapine and the heroin metabolite
6-monoacetylmorphine (O-6-MAM).
2. Materials and methods
Chemicals
OMPs were either purchased dissolved in 0.1 or 1.0 mg mL−1
solutions or as powder. Stock solutions from powders were
prepared at 1 mg mL−1 in either acetonitrile or methanol and
stored in the dark at −20 °C. All aqueous solutions were made
in ultrapure water (Milli-Q, Millipore, USA). Chemicals and
solvents (purity 95% or higher) were used as received from
various commercial suppliers. Methanol, ammonium acetate
(NH4OAc), ammonium fluoride (NH4F) and acetic acid (CH3-
COOH) for chromatographic analysis (all HPLC grade),
phosphoric acid (H3PO4), disodium phosphate (Na2HPO4),
monosodium phosphate (NaH2PO4) and sodium tetraborate
(Na2B4O7) were obtained from either Sigma-Aldrich or Fisher
Scientific, sodium thiosulfate (Na2S2O3) from Merck, sodium
hydroxide (NaOH) from PanReac.
Table 1 provides a list of the 90 OMPs studied, including
information about their estimated or known ozone reactivity. The
referenced studies consist of both mechanistic single-compound
studies and multi-compound studies. Table S1† provides CAS
number, molecular weight, formula, structure, and instrument
detection and quantification limit for each compound. Table S2†
provides second order rate constants for the reactions of the
compounds with OH radicals, when available.
Ozonation experiments
All reactions were conducted in 10 mL glass flasks. Freshly
prepared methanol stock solution containing all 90
compounds at equal mass concentration was spiked into
empty flasks. The solvent was evaporated under a gentle
stream of nitrogen followed by re-dissolution with the
aqueous phase, which consisted of either buffered ultrapure
water at pH 3 (10 mM H3PO4/H2NaPO4), pH 7 (10 mM
H2NaPO4/HNa2PO4) or pH 11 (10 mM H3BO3), tap water (total
organic carbon (TOC) 1.5 mg C L−1, pH 7.5) or secondary
wastewater effluent (TOC 7.1 mg C L−1, pH 7.8) from a
wastewater treatment plant in the Southwest of England. The
concentration of each OMP in the final reaction solution was
approximately 100 μg L−1, which translated into a TOC of 6
mg C L−1 added to the TOC of the matrix. A high initial
concentration of each OMP was chosen to avoid an analyte
concentration step prior to LC-MS (liquid chromatography
coupled with tandem mass spectrometry) analysis.
Ozone was produced with a BMT 803 N ozone generator
(BMT Messtechnik, Berlin, Germany). Stock solutions (1.3–1.5
mM, 62–72 mg L−1) were made by sparging ozone gas
through ultrapure water (≤4 °C) that was cooled in an ice
bath. The dissolved ozone concentration of stock solutions
was quantified directly spectrophotometrically using a molar
absorption coefficient of ε = 3000 M−1 cm−1 at an absorption
wavelength of λ = 258 nm.69
The ozone stock solution was added under vigorous stirring
to each flask to achieve ozone doses on a carbon basis of 0.05
mM O3 per mM C (0.2 g O3 per g C), 0.15 mM O3 per mM C
(0.6 g O3 per g C) and 0.3 mM O3 per mM C (1.2 g O3 per g C),
to cover the range used for water treatment. Specific ozone
doses on a molar basis are hereafter used. After 5 min reaction
time, the samples were quenched with 0.1 M sodium thiosulfate
(Na2S2O3) and analysed within 24 h.
Analytical methods
A detailed description of the analytical method used for the
OMPs can be found elsewhere.33 Briefly, the target
Environmental Science: Water Research & TechnologyPaper
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Table 1 Studied organic micropollutants (in alphabetical order). kO3 values are experimental or calculated by QSAR as indicated. Estimated ozone
reactivity is based on compound structure. Literature column shows reference for kO3 or other relevant study. pKa values were obtained from
33
Chemical
Mode of
action/use
pKa
(most acidic)
pKa
(most basic)
Ozone-(non) reactive
functional groups
kO3 (M
−1 s−1) at pH 7 or
estimated ozone reactivity Literature
1,7 Dimethylxanthine Human
indicator
8.5 0.2 Amide, imidazole Medium 34
10,11 Dihydro 10
hydroxycarbamazepine
Anti-epileptic
metabolite
13.8 −0.5 Amide, benzene ring Low
Acetaminophen NSAID 9.9 1.7 Benzene ring 4.1 × 106 35
Amphetamine Stimulant — 9.9 (Protonated) amine,
benzene ring
Low 27
Anhydroecgonine
methylester
Stimulant
metabolite
— 8.0 Olefin, (protonated) amine High
Atenolol Beta-blocker 13.9 9.4 Amide, (protonated) amine,
benzene ring
1.7 × 103 36
Atorvastatin Lipid regulator 4.3 0.4 Benzene ring Medium
Azathioprine Anti-cancer — 7.5 (Deactivated) thioether,
imidazole
Low 37
Azithromycin Antibiotic 13.3 8.6 (Protonated) amine 1.1 × 105 38
Benzophenone-1 UV filter 7.7 — Benzene ring High
Benzophenone-2 UV filter 7.0 — Benzene ring High 39
Benzophenone-3 UV filter 7.6 — Benzene ring 6.9 × 105 40
Benzophenone-4 UV filter −0.7 — Benzene ring Medium 41
Benzoylecgonine Stimulant
metabolite
3.4 10.8 (Protonated) amine,
deactivated benzene ring
Low 11, 27
Bezafibrate Lipid regulator 3.3 −2.1 Amide, benzene ring 590 18, 42
Bisphenol A Plasticizer 10.3 — Phenol 1.1 × 106 43
Butylparaben Parabens 8.2 — Phenol 7.9 × 107 44
Caffeine Human
indicator
— 0.5 Amide, imidazole 673 23, 45
Carbamazepine Anti-epileptic 13.9 −0.5 Olefin, amide, benzene ring 3 × 105 18, 46
Carbamazepine 10,11
epoxide
Anti-epileptic
metabolite
13.9 −0.5 Amide, benzene ring Low 24
Cetirizine Antihistamine 3.5 6.7 (Protonated) amine,
benzene ring
1.7 × 105 47
Cimetidine H2 receptor
antagonists
14.1 7.1 Thioether, amidine,
imidazole
High
Citalopram Anti-depressant — 9.6 (Protonated) amine,
deactivated benzene ring
Low 48, 49
Clarithromycin Antibiotic 13.1 8.2 (Protonated) amine 7 × 104 50
Cocaethylene Stimulant
metabolite
— 9.0 (Protonated) amine,
deactivated benzene ring
Low
Cocaine Stimulant — 9.0 (Protonated) amine,
deactivated benzene ring
Low 11, 27
Codeine Analgesic 13.4 8.2 Olefin, (protonated) amine,
benzene ring
High 24
Cotinine Human
indicator
— 4.7 Amide, pyridine Low 11, 24
Creatinine Human
indicator
— 6.9 Amide, (protonated) amine 2 51
Desmethylcitalopram Anti-depressant
metabolite
— 10.5 (Protonated) amine,
deactivated benzene ring
Low 48
Desmethylvenlafaxine Anti-depressant
metabolite
10.0 9.3 Phenol, (protonated) amine High 49
Diclofenac NSAID 4.9 −2.3 Aniline 1 × 106 18, 52
Dihydrocodeine Analgesic 14.2 8.4 (Protonated) amine,
benzene ring
Medium
Dihydromorphine Analgesic
metabolite
9.6 8.4 (Protonated) amine,
benzene ring
High
Diltiazem Calcium
channel blocker
— 8.9 (Protonated) amine,
benzene ring
High
E1 Steroid estrogen 10.3 — Phenol 9.4 × 105 43, 53
E2 Steroid estrogen 10.3 — Phenol 2.2 × 106 43, 53
EDDP Analgesic
metabolite
— 7.7 Olefin, (protonated) amine,
benzene ring
High 28
EE2 Steroid estrogen 10.2 — Phenol 2.3 × 106 43
Ephedrine/pseudoephedrine Drug precursor 14.0 9.4 (Protonated) amine,
benzene ring
Low
Ethylparaben Parabens 8.3 — Phenol 5.5 × 107 44
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Table 1 (continued)
Chemical
Mode of
action/use
pKa
(most acidic)
pKa
(most basic)
Ozone-(non) reactive
functional groups
kO3 (M
−1 s−1) at pH 7 or
estimated ozone reactivity Literature
Fexofenadine Antihistamine 4.4 9.4 (Protonated) amine,
benzene ring
9.0 × 103 47
Fluoxetine Anti-depressant — 10.1 (Protonated) amine,
benzene ring
1.6 × 104 54
Gliclazide Diabetes 6.1 3.9 Amide, (protonated) amine,
deactivated benzene ring
High
Heroin Opioid — 7.9 Olefin, (protonated) amine,
benzene ring
High
Ibuprofen NSAID 4.4 — Benzene ring 9.6 18
Ifosfamide Anti-cancer — 1.4 Phosphamide <1 (QSAR) 55
Iopromide X-ray contrast
media
10.6 −2.6 Amide, deactivated benzene
ring
<0.8 18
Irbesartan Hypertension 4.2 2.6 Amide, (protonated) amine,
benzene ring
24 25
Ketamine Anaesthetic — 6.5 (Protonated) amine,
deactivated benzene ring
Medium 27
Ketoprofen NSAID 4.2 — Deactivated benzene ring 0.40 56
Lisinopril Hypertension 2.2 10.5 (Protonated) amine,
benzene ring
Low
MDA Stimulant — 10.0 (Protonated) amine, anisole High
MDMA Stimulant — 10.3 (Protonated) amine, anisole High 11, 27
MDPV Stimulant — 8.4 (Protonated) amine, anisole Medium
Mephedrone Stimulant — 7.4 (Protonated) amine,
deactivated benzene ring
Medium
Metformin Diabetes — 12.3 (Protonated) amine 1.2 19
Methadone Analgesic — 9.5 (Protonated) amine,
benzene ring
Low 28
Methamphetamine Stimulant — 10.4 (Protonated) amine,
benzene ring
Low 27
Methotrexate Anti-cancer 3.5 5.6 Aniline, amide, (protonated)
amine
High 57
Methylparaben Parabens 8.3 — Phenol 4.8 × 107 44
Metoprolol Beta-blocker 13.9 9.4 (Protonated) amine,
benzene ring
2.0 × 103 36
Mirtazapine Anti-depressant — 8.1 (Protonated) amine,
benzene ring, pyridine
Medium 49
Morphine Analgesic 9.5 8.3 Olefin, (protonated) amine,
benzene ring
6.4 × 106 (QSAR) 55
Naproxen NSAID 4.8 — Naphthalene 2 × 105 58
N-Desmethyltramadol Analgesic
metabolite
14.5 10.6 (Protonated) amine, anisole Medium
Nicotine Human
indicator
— 8.0 (Protonated) amine,
pyridine
Medium 11, 24
Norcodeine Analgesic
metabolite
13.3 9.3 Olefin, (protonated) amine,
benzene ring
High 26
Norephedrine Stimulant
metabolite
12.1 8.5 (Protonated) amine,
benzene ring
Low
Norfluoxetine Anti-depressant
metabolite
— 9.1 (Protonated) amine,
benzene ring
65 54
Norketamine Anaesthetic
metabolite
— 6.3 (Protonated) amine,
deactivated benzene ring
Medium
Normorphine Analgesic
metabolite
9.2 9.5 Olefin, (protonated) amine,
benzene ring
High
O-6-MAM Opioid
metabolite
9.4 8.0 Olefin, (protonated) amine,
benzene ring
High
O-Desmethyltramadol Analgesic
metabolite
10.0 9.6 (Protonated) amine, phenol High
Pholcodine Cough
suppressant
13.4 8.2 Olefin, (protonated) amine,
benzene ring
High
Propranolol Beta-blocker 13.8 9.5 Naphthalene, (protonated)
amine
1 × 105 36
Propylparaben Parabens 8.2 — Phenol 7.0 × 107 44
Quetiapine Anti-psychotic 14.4 6.7 Amidine, benzene ring,
thioether
High
Ranitidine H2 receptor
antagonists
— 8.4 Amidine, furan, thioether 2.1 × 106 59
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compounds were analysed by liquid chromatography-tandem
mass spectrometry (LC-MS) using a Waters Acquity UPLC
system (Waters, Manchester, UK) coupled to a Xevo TQD
(Triple Quadrupole Mass Spectrometer, Waters, Manchester,
UK) equipped with an electrospray ionisation source. The
determination of acidic and basic compounds was performed
Fig. 1 A. Simultaneous removal of 90 organic micropollutants added to pure buffered water as a function of the specific ozone dose and the pH
(arranged with increasing average removal at pH 7). Error bars from duplicate analysis of samples were omitted for figure overview and are
provided in the ESI† xlsx-data file. B. Simultaneous removal of 90 organic micropollutants added to pure buffered water as a function of the
specific ozone dose and the pH (arranged with increasing average removal at pH 7). Error bars from duplicate analysis of samples were omitted for
figure overview and are provided in the ESI† xlsx-data file.
Table 1 (continued)
Chemical
Mode of
action/use
pKa
(most acidic)
pKa
(most basic)
Ozone-(non) reactive
functional groups
kO3 (M
−1 s−1) at pH 7 or
estimated ozone reactivity Literature
Sertraline Anti-depressant — 9.5 (Protonated) amine,
benzene ring
Medium 49
Sulfamethoxazole Antibiotic 5.8 1.4 Aniline, sulfonamide 2.6 × 106 18, 60
Sulfasalazine Antibacterial 2.7 0.9 Benzene ring, sulfonamide High
Tamoxifen Anti-cancer — 8.7 Olefin, benzene ring High 61
Temazepam Hypnotic 11.7 1.6 Amide, deactivated benzene
ring
Low 62
Tramadol Analgesic 14.5 9.6 (Protonated) amine, anisole 2.2 × 103 63
Triclosan Antibacterial 7.8 — Benzene ring 3.8 × 107 64, 65
Trimethoprim Antibiotic — 7.0 (Protonated) amine,
pyrimidine, benzene ring
2.7 × 105 38, 66
Tylosin Veterinary 13.1 7.4 Olefin, (protonated) amine 5.1 × 105 38
Valsartan Hypertension 3.6 0.6 Amide, benzene ring 38 (QSAR) 55, 67
Venlafaxine Anti-depressant 14.8 9.3 (Protonated) amine, anisole 1.3 × 103 49, 68
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in negative and positive ionisation mode, respectively. Limits
of quantification and detection for individual analytes are
presented in Table S1.† Each sample was analysed in
duplicate. Method performance is described in detail
elsewhere.33
Total organic carbon was analysed with a Shimadzu TOC-
VCPN Analyzer (Shimadzu, Kyoto, Japan). Spectroscopic
measurements were conducted with a Cary 100 UV–Vis
Spectrometer (Agilent Technologies, Santa Clara, California,
USA).
Ozone and OH radical exposures
The exposure (time-integrated concentration) of OH radicals
was estimated from the elimination percentage of ketoprofen
(KET). Ketoprofen was selected because it is the compound
with the lowest ozonation second order rate constant (0.4
M−1 s−1) among the compounds included in this study (see
Table 1). Additionally, ketoprofen has a known and high
second order rate constant for its reaction with OH radicals
(see Table S2). Therefore, its reaction with ozone can be
considered negligible, while the OH radical exposure was
calculated based on eqn (1):
kOH=KET
ð
OH½ dt ¼ − ln KET½ 
KET½ 0
 
(1)
The ozone exposure was then estimated from the elimination
percentage of carbamazepine (CBZ), or tramadol (TRA) in
cases when carbamazepine was below the limit of
quantification after ozonation. Carbamazepine has a high
ozone reactivity that does not depend on the pH, while
tramadol has a moderate ozone reactivity that does depend
on the pH, which was considered (see Table 1). The ozone
exposure was calculated from eqn (2):
kOH=CBZorTRA
ð
OH½ dt þ kO3=CBZorTRA
ð
O3½ dt¼ − ln CBZ or TRA½ CBZ or TRA½ 0
 
(2)
3. Results and discussion
Abatement by ozonation of organic micropollutants including
illicit drugs added to pure water at pH 7
An overview of the elimination of the 90 OMPs by ozonation
in pure buffered water at three different pH values and at
three specific ozone doses is shown in Fig. 1. As expected by
the chemical diversity of the OMPs (see Table 1 and Table
S1†), the results range from no removal to complete removal.
At the highest ozone dose of 0.3 mM O3 per mM C and at pH
7 almost half of all compounds were removed to below the
limit of detection. The medium ozone dose of 0.15 mM O3
per mM C at pH 7 led to 80% or higher removal for more
than a third of compounds. At the lowest ozone dose of 0.05
mM O3 per mM C at pH 7 partial removal occurred for most
compounds.
The OMPs may be classified into three groups according
to their attenuation at the highest specific ozone dose at pH
7: group I compounds were readily removed by more than
90%, group II compounds had a moderate removal of 50 to
90% and group III compounds were hard to remove with less
than 50% removal. Group I consisted of 47 (52%) of the
tested compounds, 10 compounds (11%) were in group II,
while 33 (37%) were in group III. Similar classifications of
OMPs have been used in previous studies, with comparable
elimination observed in municipal and hospital wastewater
effluent at the same specific ozone doses.32,55 However, it
should be noted that high concentrations of OMPs in waters
with a low scavenger concentration (in this case pure
buffered water) may affect the ozone and OH radical
exposures,70 and therefore the observed OMP elimination
(see also below discussion on ozone and OH radicals
exposures).
Group III included most illicit stimulants, antidepressants
and their metabolites. These compounds exhibit no
functional groups that are readily reactive with ozone. As an
electrophile, ozone reacts selectively with electron-rich
moieties, such as neutral amines, activated benzene rings
and olefins.16 Compounds in group III include deactivated
benzene rings (e.g. ketoprofen, cocaine), amides (e.g.
cotinine, ifosfamide) and protonated amines (e.g. citalopram,
metformin), which have second order rate constants with
ozone <10 M−1 s−1 (see Table 1). Their elimination can be
attributed to reaction with less selective OH radicals. The OH
radical second order rate constants (kOH) of most OMPs vary
by only one order of magnitude, between 109 M−1 s−1 and
diffusion-controlled values of 1010 M−1 s−1 (see Table S2).
Group III compounds can be more effectively attenuated with
advanced oxidation processes (AOPs) that aim to increase the
concentration of OH radicals, such as the peroxone process
(O3/H2O2) or ultraviolet (UV) light combined with hydrogen
peroxide (UV/H2O2).
15
Few compounds such as the carbamazepine metabolites
carbamazepine-10,11-epoxide and 10,11-dihydro-10-
hydroxycarbamazepine, exhibited unclear elimination trends
with increasing ozone dose, which may be ascribed to
simultaneous degradation and formation from the oxidation of
structurally similar compounds. Azathioprine had the lowest
removal of all compounds in this study, and there is only
limited information about its ozone reactivity in the literature.37
Most antibacterial agents and antibiotics, analgesics and
their metabolites, UV filters, parabens and steroid estrogens
belong to Group I and exhibit high elimination with ozone.
Group I compounds contain moieties known to react fast
with ozone: activated benzene rings, such as phenols (e.g.
methylparaben, estrone, bisphenol A) and anilines (e.g.
methotrexate, diclofenac), amines (e.g. mirtazapine,
gliclazide), olefins (e.g. morphine, pholcodine) and thioethers
(e.g. ranitidine). Note that several compounds contain more
than one ozone-reactive sites.
The illicit drugs and illicit drug metabolites included in
this study fall into four categories: opioids (heroin, O-6-MAM,
Environmental Science: Water Research & TechnologyPaper
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morphine, normorphine, dihydromorphine, methadone,
EDDP), cocainics (cocaine, cocaethylene, benzoylecgonine,
anhydroecgonine methylester), amphetamine-type
(amphetamine, methamphetamine, mephedrone,
norephedrine, ephedrine/pseudoephedrine [a precursor]) and
ecstasy group (MDMA, MDA, MDPV). Fig. 2 provides an
overview on the elimination of the four substance categories
at five different specific ozone doses in pure buffered water
at pH 7.
Five of the opioids (heroin, O-6-MAM, morphine,
normorphine, dihydromorphine) have a similar molecular
structure. They contain an activated benzene ring (phenol or
Fig. 2 Abatement of illicit drugs and their metabolites as a function of the specific ozone dose in pure buffered water at pH 7. All compounds
were added as a mixture of 90 OMPs in total. Error bars from duplicate analysis of samples were omitted for figure overview and are provided in
the ESI† xlsx-data file.
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anisole), a tertiary or secondary amine (pKa = 7.9–9.6) and,
apart from dihydromorphine, a carbon double bond. These
opioids are efficiently removed by ozonation at pH 7. Second
order rate constants for reactions of opioids with ozone have
not been determined experimentally, while for morphine the
rate constant has been estimated with a QSAR approach as
6.4 × 106 M−1 s−1.55 Second order rate constants of other
structurally similar opioids can be expected to be close to this
value. Since dihydromorphine appears to have the same
ozone reactivity as morphine, the primary site of ozone attack
at pH 7 is likely the activated benzene ring rather than the
olefinic bond. In contrast, methadone and its metabolite
EDDP were both poorly removed by ozonation at pH 7,
despite EDDP having a carbon double bond. Only partial
removal of these two compounds has been observed in
waterworks employing different treatment methods, while
trace concentrations of both compounds have been detected
in finished drinking water.28,71
Cocaine and two of its metabolites (cocaethylene and
benzoylecgonine) have similar structures containing a
deactivated benzene ring (carbonyl-substituted) and a
protonated amine (pKa = 9–10.8). As a result, their reactivity with
ozone is low and minimal removal at pH 7 was observed.
Cocaine has been shown to be more ozone reactive than
benzoylecgonine,27 which was not observed in this study, due to
the very low removal of both compounds. These three cocainics
have been found as traces in tap water of different
countries.71,72 In contrast, anhydroecgonine methylester (a
biomarker for the use of crack cocaine) contains an olefinic
bond and has a lower pKa of 8. Accordingly, as shown in Fig. 2,
this compound has a much higher ozonation removal than the
other compounds in this category.
The amphetamine-type compounds contain a deactivated
or slightly activated benzene ring and an amine (pKa = 7.4–
10.4). Fig. 2 shows that all amphetamine-type compounds
were ozone-resistant at pH 7. Mephedrone and
methamphetamine have been detected in drinking water
samples from the UK, which had undergone treatment
including ozonation.12 Methamphetamine is reported to be
more ozone-reactive than amphetamine due to the presence
of a secondary rather than a primary amine.27 This was not
observed in this study due to the very low removal of both
compounds under the employed conditions. However, this
effect could be observed for ephedrine/pseudoephedrine
which had a higher elimination than norephedrine.
Drugs of the ecstasy group contain a benzene ring
activated by two anisole substituents, and an amine with pKa
of 8.4–10.3 (primary-MDA, secondary-MDMA, tertiary-MDPV).
The main reactive site is expected to be the benzene ring
leading to high removal. MDA and MDMA differ by only one
methyl group attached to the amine and showed the same
ozone reactivity, while MDPV contains an additional carbonyl
substituent on the benzene ring, inducing partial
deactivation and lower reactivity. MDMA has been detected
in surface water and was only partly removed during the
ozonation step of drinking water production.11
Effect of pH on micropollutant abatement by ozone in pure
buffered water
Changes in pH strongly affect ozone chemistry in water. An
elevated pH leads to faster ozone decay due to two
phenomena: hydroxide ions initiate the chain reaction of
ozone decomposition and at the same time electrophilic
ozone reacts faster with deprotonated or dissociated species
of the dissolved organic matter.73,74 In the experimental
system of this study the latter phenomenon is expected to be
more important due to the increased concentrations of
OMPs. Deprotonated alkylamines (typical pKa = 9–11) have up
to six orders of magnitude higher reactivity with ozone than
the protonated species.29 The second order rate constant for
the reaction of ozone with dissociated phenolic compounds
is five orders of magnitude higher compared to the
corresponding non-dissociated species.30 Despite lower ozone
exposure at higher pH, the OH radical exposure remains
roughly constant with pH in natural waters.73
The estimated ozone and OH radical exposures in pure
buffered water under each set of conditions are shown in
Table 2 (tap water and wastewater effluent are discussed in
the next section). At a given specific ozone dose, the ozone
exposure increased by two orders of magnitude as the pH
decreased by 4 units. The OH radical exposure remained
roughly constant within the uncertainty of the employed
estimation method (approximately accurate within an order
of magnitude). The ozone exposure values at pH 3 and 7 were
of the same order of magnitude as those measured in natural
waters,73 while those at pH 11 were lower and accompanied
by slightly higher OH radical exposures. It should be noted
that samples were quenched of residual ozone after 5
minutes of reaction, which may have resulted in lower ozone
Table 2 Estimated ozone and OH radical exposures in each water matrix and specific ozone dose, calculated from the elimination of carbamazepine/
tramadol and ketoprofen, respectively
Specific ozone dose
(mM O3 per mM C)
OH radical exposure (M s) Ozone exposure (M s)
0.05 0.15 0.30 0.05 0.15 0.30
Buffered at pH 3 7 × 10−12 9 × 10−12 6 × 10−12 3 × 10−4 4 × 10−3 3 × 10−2
Buffered at pH 7 4 × 10−12 3 × 10−12 8 × 10−12 3 × 10−6 4 × 10−5 4 × 10−4
Buffered at pH 11 8 × 10−12 1 × 10−11 2 × 10−11 6 × 10−8 3 × 10−7 7 × 10−7
Tap water 1 × 10−13 6 × 10−12 1 × 10−11 5 × 10−7 1 × 10−6 5 × 10−6
Wastewater effluent 1 × 10−11 7 × 10−12 2 × 10−11 3 × 10−7 1 × 10−6 3 × 10−6
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exposure than the maximum possible. The ratio of OH
radical exposure to ozone exposure, i.e. the Rct value,
75 was in
the range of 10−4 to 10−10 across the three pH levels.
The combined effect of different ozone exposure and
target compound speciation has led to different removal
trends among the 90 OMPs (Fig. 1). The amines fluoxetine
(pKa = 10.1) and sertraline (pKa = 9.5) were better removed at
higher pH due to deprotonation. In contrast, the four
parabens (phenols with pKa of 8.2 to 8.3) followed a distinct
trend: their removal increased with a change of pH from 3 to
7 (due to increased dissociation of the phenols which
enhanced their ozone reactivity) and then decreased at pH 11
(due to lower ozone exposure). The four benzophenones
followed the same trend. However, the removal of the
phenolic hormones E1, E2 and EE2 and the plasticizer
bisphenol A decreased with higher pH, indicating that the
increased reactivity of the dissociated form was outweighed
by the lower ozone exposure. For olefins, such as
carbamazepine and tamoxifen, a sharp drop of removal was
observed at pH 11. In these cases, the effect of the pH is only
due to the different ozone and OH radical exposures.
The effect of the pH on the ozonation of illicit drugs and
their metabolites was also examined. Four of the opioids with
structure similar to morphine have a phenolic moiety with
pKa > 9. However, the effect of the pH change on their
removal seems to be mainly due to the different ozone
exposure rather than the dissociation of the phenolic moiety.
Decreased elimination was observed with an increase of pH
from 3 to 7 but only at the lowest ozone dose. At pH 11
removals were markedly lower than those at pH 3 and 7, with
the highest one being 61% for dihydromorphine and the
lowest being 21% for O-6-MAM. In contrast, methadone was
better removed at higher pH due to deprotonation of its
amine moiety (pKa = 9.5) and reached 50% removal at pH 11
with the highest ozone dose. The removal of EDDP also
slightly increased with pH but remained poor (<20%) under
all conditions.
Cocaine, cocaethylene and benzoylecgonine showed
enhanced removal at pH 11, since their main ozone-reactive
moiety is an amine (pKa = 9–10.8). Despite this increase, their
removal was still below 35%. The fourth compound of the
cocainics class, anhydroecgonine methylester, is an olefin
and showed decreased elimination at pH 11 due to lower
ozone exposure. The amphetamine-type compounds were
ozone-resistant at all pH values (removal below 35%), but an
increase of removal was observed at pH 11 due to
deprotonation of the amine (pKa = 7.4–10.4). The removal of
MDA and MDMA decreased at higher pH due to the lower
ozone exposure, as their main ozone-reactive site is an
activated benzene ring. The less reactive MDPV showed a
slight increase of removal at pH 11, indicating that the amine
(pKa = 8.4) plays a more important role in its reaction with
ozone due to partial deactivation of its benzene ring.
An overview of the complete dataset is presented as box
and whisker plots in Fig. 3. Since a similar broad range of
compounds can be expected in real water matrices, such as
river water,33 the box and whisker plots provide a rough
estimation on ozonation performance for multi-compound
mixtures. Overall, the optimal pH for the elimination of the
selected OMPs was 3 and 7. At pH 3 higher removal
compared to pH 7 was observed at the lowest ozone dose,
while the removal was similar at the other two applied ozone
doses. Ozonation at pH 11 was ineffective and would require
higher ozone doses to yield results like those of the lower pH
values. The only compounds whose removal improved at pH
11 were Group II and III compounds, including amines with
pKa > 7. Typical pH for ozonation in treatment practice is 7
to 8.5.
Removal in tap water and wastewater effluent
Although the ozone dose was normalised to the TOC
concentration, the dissolved organic carbon in each water
matrix used has different characteristics. In pure buffered
water, the organic matter consists of the added OMPs, while
in tap water and wastewater effluent it also includes the bulk
organic matter. The bulk organic matter was 20% of the total
TOC in tap water and 54% in wastewater effluent (on a mass
Fig. 3 Box and whisker plots of the removal of the 90 OMPs under the different conditions used in this study. %ile: percentile.
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basis). The ozone reactivity of bulk organic matter varies
depending on the origin and characteristics of the sample,
and typically covers a range of several orders of magnitude.76
Different fractions of dissolved organic matter promote or
inhibit ozone decay and the production of OH radicals,
leading to different ozone and OH radical exposures.16,77 The
characteristics of the organic matrix, such as aromaticity,
protein and humic acid content, were not determined in this
study.
As shown in Table 2, the ozone exposure in tap water (pH
7.5) and wastewater effluent (pH 7.8) was one to two orders
of magnitude lower than the one in pure buffered water at
pH 7, but higher than that at pH 11. For most of the
compounds that react fast with ozone, the removal in tap
water or wastewater effluent decreased compared to pure
buffered water at pH 7 (see ESI† xlsx-data file). This matrix
effect is also evident in Fig. 3, especially at the intermediate
ozone dose (0.15 mM O3 per mM C) and can be attributed to
partial ozone consumption by the bulk organic matter. With
0.15 mM O3 per mM C, no compound was removed by more
than 90% in tap water or wastewater effluent. The maximum
removal in tap water at this ozone dose was 79%
(cimetidine), while in wastewater effluent it was 60%
(triclosan). At the highest ozone dose (0.30 mM O3 per mM
C) removal of cimetidine and normorphine to below the limit
of detection was achieved in tap water, but removal was
partial for all compounds in wastewater effluent.
The water matrix had a smaller effect on the OH radical
exposure and the elimination of ozone-resistant compounds
(Table 2 and ESI† xlsx-data file). Due to their high
concentrations, the OMPs already reacted very fast with OH
radicals in pure buffered water. Therefore, no additional
scavenging of OH radicals by the bulk organic matter in tap
water and wastewater effluent was observed. For a few
compounds, such as citalopram, ibuprofen and valsartan,
even an enhanced elimination in tap water or wastewater
effluent was noticed as a result of a slightly increased OH
radical exposure. The average Rct value was 2 × 10
−5 in
wastewater effluent and 2 × 10−6 in tap water, which was
higher compared to previously reported values for wastewater
effluent.78,79
Fig. 4 shows the elimination of 40 OMPs with known
second order rate constants for their reaction with ozone,
added in tap water and wastewater effluent. Data including
compound names are provided in the ESI.† Overall, at the
lowest specific ozone dose, ozone reactivity had a small effect
on the removal of the OMPs in tap water or wastewater
effluent, as all 40 compounds were poorly removed (<50%
removal). The effect of ozone reactivity became obvious at the
intermediate and the highest ozone dose.
4. Conclusions
We conducted the simultaneous ozonation of 90 OMPs
including illicit drugs and their metabolites in different
aqueous matrices. Target compounds were chosen based on
their relevance for current and future legislation and their
environmental occurrence, persistence and toxicity. Forty-
seven of the tested compounds were readily removed by
ozone, including most antibacterials, antibiotics, analgesics,
UV filters, parabens and steroids since these compounds
contained moieties that are highly reactive with ozone.
Compounds that were hard to remove with ozone contained
deactivated benzene rings, amide and protonated amine
moieties that are unreactive with ozone and included most
illicit stimulants, antidepressants and their metabolites. This
study provides a valuable database of both literature and
experimental results on a wide range of OMPs, including
some compounds not studied with ozone before. We
specifically focused on discussing results for illicit drugs,
including their occurrence in drinking water because
ozonation of illicit drugs and their metabolites is
significantly less studied compared to the pharmaceuticals
and other compounds investigated here. The results of this
study are important to predict the performance of ozonation
for the removal of trace organic contaminants during water
treatment.
Fig. 4 Removal of 40 OMPs in wastewater effluent and tap water versus their known from the literature ozonation second order rate constants.
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Compound
pH 7 
0.05
pH 7 
0.10
pH 7 
0.15
pH 7 
0.20
pH 7 
0.30
pH 3 
0.05
pH 3 
0.15
1,7 dimethylxantine 16.6 26.7 46.4 83.7 100.0 15.3 53.7
10,11 dihydro 10 hydroxycarbamazepine 13.9 19.4 18.9 15.5 10.6 19.2 23.0
Acetaminophen 35.4 71.9 93.8 94.8 99.2 91.2 100.0
Amphetamine 6.5 10.0 9.3 10.6 11.1 5.5 6.4
Anhydroecgonine methylester 8.3 23.3 30.7 57.0 94.7 4.6 67.0
Atenolol -6.6 4.1 4.8 8.2 25.5 7.6 18.5
Atorvostatin 67.2 66.5 65.8 64.5 62.8 100.0 100.0
Azathioprine -3.7 -17.1 -20.1 -23.1 -23.4 -30.0 -32.6
Azithromycin 19.7 25.3 28.0 50.7 94.6 3.4 8.3
Benzophenone1 37.8 73.6 99.1 100.0 100.0 14.8 83.8
Benzophenone2 57.8 90.3 100.0 100.0 100.0 23.1 100.0
Benzophenone-3 11.8 28.9 42.5 60.6 60.7 -0.6 23.0
Benzophenone4 8.8 19.8 32.4 66.8 100.0 -3.9 10.7
Benzoylecgonine 7.3 9.6 7.8 7.0 6.9 8.8 9.9
Bezafibrate 6.7 11.6 11.5 26.5 87.7 8.2 33.0
Bisphenol A 23.1 47.1 84.8 100.0 100.0 39.8 100.0
Butylparaben 25.8 56.3 91.2 99.8 100.0 10.5 46.0
Caffeine 6.2 11.5 9.8 25.1 95.0 15.8 71.8
Carbamazepine 60.8 96.1 100.0 100.0 100.0 100.0 100.0
Carbamazepine 10,11 epoxide 14.3 20.1 21.2 20.4 8.7 17.2 24.3
Cetirizine 14.9 27.6 38.0 78.7 100.0 16.5 99.9
Cimetidine 72.4 99.9 100.0 100.0 100.0 100.0 100.0
Citalopram 9.1 11.3 9.9 12.3 30.4 5.9 4.9
Clarithromycin 11.0 18.5 16.9 32.3 82.3 3.6 5.4
Cocaethylene 6.5 9.9 7.2 6.0 10.2 7.6 7.6
Cocaine 6.0 8.8 5.0 5.6 11.3 6.8 9.3
Codeine 53.4 93.2 99.4 100.0 100.0 100.0 100.0
Cotinine 5.0 6.0 4.7 2.1 2.6 6.9 5.6
Creatinine 32.8 40.6 45.1 47.0 54.6 19.3 18.3
Desmethylcitalopram 5.2 5.2 3.6 2.9 5.9 -0.8 0.6
Desvenlafaxine 17.9 41.0 74.4 100.0 100.0 7.3 50.4
Diclofenac 53.9 85.0 100.0 100.0 100.0 72.3 100.0
Dihydrocodeine -32.3 54.4 100.0 100.0 100.0 100.0 100.0
Dihydromorphine 72.2 100.0 100.0 100.0 100.0 100.0 100.0
Diltiazem 24.5 41.1 59.3 92.0 100.0 25.2 53.6
E1 35.3 70.0 100.0 100.0 100.0 85.1 100.0
E2 35.0 75.0 100.0 100.0 100.0 91.9 100.0
EDDP 8.2 10.8 6.8 6.0 7.9 6.0 8.6
EE2 36.4 70.2 100.0 100.0 100.0 81.0 100.0
Ephedrine/pseudoephedrine 7.3 11.4 14.5 17.5 20.4 8.5 17.0
Ethylparaben 27.7 56.8 91.4 100.0 100.0 8.4 40.7
Fexofenadine 13.6 15.9 18.3 17.0 32.8 8.2 8.3
Fluoxetine 13.5 18.4 16.0 14.4 19.5 8.8 13.8
Gliclazide 45.8 82.0 93.9 100.0 100.0 30.9 100.0
Heroin 29.6 60.9 93.6 100.0 100.0 69.4 100.0
Remova             
Ibuprofen 4.2 5.5 4.1 4.5 9.3 10.4 7.6
Ifosfamide 2.8 6.1 0.8 0.3 7.0 1.7 3.9
Iopromide 17.2 23.7 23.7 22.9 24.4 32.3 30.9
Irbesartan 7.5 11.3 10.4 12.6 10.6 6.6 10.1
Ketamine 2.9 5.9 3.2 4.5 27.2 7.7 6.6
Ketoprofen 3.1 7.3 2.3 2.1 6.4 5.8 7.6
Lisinopril 6.5 9.2 12.0 13.3 18.6 12.3 19.0
MDA 20.0 42.6 74.1 99.2 100.0 52.3 100.0
MDMA 19.9 46.1 75.7 99.8 100.0 51.6 100.0
MDPV 6.0 8.0 7.0 17.4 64.0 8.2 19.5
Mephedrone 3.9 4.4 6.0 3.4 17.4 4.8 4.1
Metformin 14.6 13.9 9.7 6.6 6.9 9.2 6.4
Methadone 8.7 12.7 9.4 10.2 17.4 6.0 11.1
Methamphetamine 6.7 10.0 9.0 6.8 9.8 7.1 6.5
Methotrexate 77.3 100.0 100.0 100.0 100.0
Methylparaben 26.9 56.1 90.9 99.6 100.0 9.9 45.6
Metoprolol 4.8 9.7 8.5 16.6 65.3 8.0 39.9
Mirtazapine 19.5 41.6 73.4 97.9 100.0 22.2 97.7
Morphine 73.2 100.0 100.0 100.0 100.0 100.0 100.0
Naproxen 56.3 93.0 100.0 100.0 100.0 100.0 100.0
N-desmethyltramadol 6.2 9.2 7.8 16.1 61.1 5.8 33.0
Nicotine 33.0 47.1 61.6 86.7 94.0 34.8 82.7
Norcodeine 56.3 95.3 100.0 100.0 100.0 100.0 100.0
Norephedrine -1.2 -4.9 -2.0 0.4 1.5 -3.1 7.0
Norfluoxetine 13.2 20.7 20.3 18.4 20.2 4.4 4.1
Norketamine 6.6 5.6 2.1 1.9 8.0 8.2 10.6
Normorphine 77.8 100.0 100.0 100.0 100.0 100.0 100.0
O-6-MAM 54.5 95.8 100.0 100.0 100.0 100.0 100.0
O-desmethyltramadol 19.5 43.1 78.9 100.0 100.0 11.6 63.3
Pholcodine 59.3 97.3 100.0 100.0 100.0
Propranolol 41.4 83.2 100.0 100.0 100.0 100.0 100.0
Propylparaben 27.5 56.2 91.0 99.5 99.8 9.9 46.7
Quetiapine 32.8 67.6 97.9 100.0 100.0 38.8 100.0
Ranitidine 80.2 100.0 100.0 100.0 100.0 100.0 100.0
Sertraline 18.9 25.6 19.3 22.0 30.4 5.8 7.5
Sulfamethoxazole 48.4 82.5 96.6 97.0 97.3 82.9 96.5
Sulfasalazine 2.8 17.6 36.4 80.7 89.0 -4.8 80.5
Tamoxifen 54.0 69.3 85.1 93.6 93.8 60.0 89.1
Temazepam 7.5 10.3 10.5 10.1 14.4 7.9 11.2
Tramadol 6.4 10.9 10.1 20.4 61.1 6.8 31.3
Triclosan 61.2 100.0 100.0 100.0 100.0 19.4 100.0
Trimethoprim 31.9 69.6 99.4 100.0 100.0 90.6 100.0
Tylosin 63.3 93.0 100.0 100.0 100.0 100.0 100.0
Valsartan -0.3 -4.4 -4.6 -4.3 -12.2 -2.4 -1.0
Venlafaxine 5.8 8.6 6.6 8.9 37.3 4.8 19.3
pH 3 
0.30
pH 11 
0.05
pH 11 
0.15
pH 11 
0.30
Tap water 
0.05
Tap water 
0.15
Tap water 
0.30
Wastewater 
0.05
93.0 10.2 20.3 41.2 15.6 46.4 83.1 22.3
21.6 2.2 7.0 10.9 4.5 8.7 15.7 9.6
100.0 10.7 20.1 34.5 17.3 52.1 86.7 23.0
8.7 5.8 9.3 8.6 1.8 7.9 17.9 8.2
84.0 7.0 15.7 38.5 8.0 15.9 42.7 8.4
55.8 9.8 18.7 28.9 3.2 8.1 16.5 8.2
100.0 25.7 32.7 57.0 24.0 62.9 79.5 30.1
-23.6 5.3 5.6 9.8 0.0 -1.5 -7.5 5.9
16.1 25.2 31.1 53.8 11.1 31.4 68.8 18.4
100.0 12.4 17.8 42.6 0.2 52.5 99.5 24.6
100.0 8.8 15.7 44.6 24.2 65.7 97.2 23.7
42.7 26.0 32.1 53.8 11.9 47.0 76.8 25.2
33.6 8.8 17.0 40.4 14.9 42.8 81.2 18.9
10.3 8.1 14.1 18.3 -2.6 2.2 8.7 8.0
84.6 8.3 12.5 14.3 1.3 5.0 9.0 8.3
100.0 15.2 26.3 46.3 25.4 55.9 92.7 20.0
97.9 9.6 21.2 40.5 21.0 57.4 94.3 30.7
100.0 3.6 5.6 8.0 -1.7 -4.3 -0.4 4.6
100.0 8.3 17.4 29.6 13.2 39.3 80.5 17.3
21.0 6.8 10.4 16.9 4.4 13.0 24.1 11.2
100.0 25.3 28.4 46.9 1.8 24.2 62.5 21.7
100.0 15.4 21.7 38.4 22.2 79.3 100.0 26.1
9.4 18.3 24.1 43.8 5.3 10.1 31.9 11.7
9.1 28.4 34.6 59.1 2.8 20.1 61.2 18.6
8.1 14.3 21.8 31.9 2.1 1.4 13.0 9.2
10.3 12.2 21.4 28.6 2.3 7.7 15.9 6.3
100.0 10.6 15.6 32.5 16.4 46.1 84.4 19.1
1.6 6.1 8.5 9.4 -4.1 -2.6 4.5 7.2
23.9 16.0 30.0 -23.1 1.6 6.2 14.9 7.0
2.4 -1.4 5.3 17.6 3.6 8.9 21.9 11.5
100.0 10.4 18.5 39.7 16.8 47.6 93.0 18.0
100.0 15.4 20.4 37.8 14.7 45.5 86.5 19.7
100.0 10.3 18.3 35.7 8.2 31.1 74.8 20.2
100.0 4.8 21.3 60.6 21.6 63.3 96.6 31.4
100.0 18.2 48.2 86.7 22.2
100.0 14.9 21.4 47.0 17.4 49.4 89.7 27.9
100.0 11.7 22.8 49.6 9.9 53.2 88.4 19.4
9.0 9.3 11.2 16.5 -1.5 0.2 7.3 6.9
100.0 6.5 19.9 47.4 8.1 44.9 80.5 18.1
26.4 9.9 23.4 38.9 2.0 10.1 21.0 10.3
99.4 11.7 22.2 45.6 22.1 62.1 95.8 28.0
16.0 27.5 33.8 66.6 10.6 17.9 27.5 15.4
13.2 31.5 36.3 52.7 2.5 3.8 18.8 14.3
100.0 1.3 7.5 19.4 17.3 54.1 86.5 13.0
100.0 10.2 47.3 87.5 21.3
al (%) in each water matrix and specific ozone dose (mM O3/mM C)
11.8 13.1 22.6 16.6 42.0 47.8 50.4 15.6
10.8 7.0 6.3 11.0 -1.4 1.0 2.5 3.6
29.1 11.0 16.5 19.7 -2.5 8.4 13.2 8.7
15.8 22.4 23.3 32.8 -0.4 2.8 3.8 8.4
4.6 8.2 14.2 18.7 6.2 11.7 29.5 9.0
4.7 6.2 10.3 13.0 0.1 5.2 11.5 9.8
25.4 8.5 11.5 17.8 1.4 11.2 23.6 10.0
100.0 13.5 20.3 33.8 2.4 10.5 36.4 2.6
100.0 10.2 16.2 33.1 4.9 15.3 40.7 10.2
63.8 19.7 30.3 50.9 -0.2 15.2 46.5 15.2
2.1 13.3 19.2 30.6 3.9 9.7 32.3 14.4
7.7 7.6 10.1 16.2 0.0 4.1 11.6 5.1
12.1 21.3 30.7 49.6 2.1 7.1 17.9 12.2
9.6 11.9 18.8 32.0 -0.1 4.3 14.3 8.8
-0.8 0.7 11.3 14.6 48.6 88.2 17.7
97.0 10.0 21.5 42.9 15.3 55.8 93.4 21.8
92.9 10.6 17.8 32.3 2.6 7.2 15.8 7.6
100.0 11.4 19.8 35.6 13.3 45.1 88.3 25.4
100.0 11.5 23.6 46.6 19.8 66.5 97.9 30.9
100.0 8.1 15.7 27.5 12.2 39.9 79.6 17.3
93.1 18.4 31.9 48.5 -1.6 3.8 8.8 10.8
100.0 5.4 16.4 36.8 14.3 40.2 75.8 16.6
100.0 5.8 14.7 33.2 13.9 43.1 80.2 22.3
13.6 7.0 12.7 17.0 1.0 0.3 0.8 9.2
-1.5 31.7 34.1 47.6 2.3 9.9 23.0 13.2
14.4 7.2 12.2 12.9 0.4 5.2 15.3 7.6
100.0 13.4 23.4 55.9 26.8 71.7 100.0 26.4
100.0 1.3 6.7 20.7 17.3 58.0 97.1 24.5
100.0 9.4 18.1 39.0 10.9 45.0 88.9 20.7
24.1 31.4 42.0 21.9 58.0 91.5 28.3
100.0 11.7 16.3 36.9 6.5 30.7 72.3 11.2
99.7 11.7 20.9 43.8 19.0 56.0 93.1 26.8
100.0 13.4 20.5 38.1 11.7 42.4 86.6 19.4
100.0 2.7 11.0 31.1 14.0 52.5 90.5 17.4
14.2 29.8 31.3 45.7 2.6 10.1 19.0 13.5
100.0 10.0 17.1 29.6 14.3 47.3 83.7 17.6
100.0 15.4 22.1 45.6 -3.6 12.5 46.8 22.0
89.2 45.9 40.5 53.4 32.4 41.4 70.5 29.0
11.5 7.0 6.6 8.9 -1.5 1.4 5.8 8.6
87.8 9.9 16.7 32.3 1.2 10.0 27.9 8.7
100.0 33.4 39.2 62.9 27.4 63.2 83.8 41.9
100.0 15.0 20.1 32.8 12.2 39.9 83.3 17.2
100.0 31.1 36.1 61.5 8.6 49.8 95.7 22.8
5.3 5.2 9.7 22.1 1.6 13.0 17.2 16.1
59.9 8.3 16.5 32.2 -0.6 4.7 15.8 8.4
Wastewater 
0.15
Wastewater 
0.30 pH 7 0.05 pH 7 0.10 pH 7 0.15 pH 7 0.20 pH 7 0.30
43.5 80.6 1.4 2.6 2.1 0.5 0.4
6.5 10.3 0.8 0.5 0.4 0.9 0.9
41.8 80.0 1.5 2.0 1.9 1.9 1.9
8.3 15.8 1.0 0.8 0.8 1.0 1.7
24.5 54.2 2.2 0.6 1.0 0.5 0.6
6.7 13.3 4.2 0.7 0.7 1.0 0.3
48.4 77.7 2.4 2.4 2.5 2.3 2.3
-0.5 0.0 1.4 2.3 1.4 1.3 2.2
33.5 72.3 0.4 0.6 0.2 1.3 0.3
46.9 90.4 1.1 0.6 0.7 0.7 0.7
47.9 92.0 1.5 0.4 0.4 0.4 0.4
44.5 75.3 1.2 0.3 0.2 0.2 0.3
39.0 77.3 0.5 1.5 0.3 1.7 0.3
7.8 16.1 0.5 0.3 0.3 0.3 1.0
5.8 10.9 2.0 2.1 2.1 2.0 2.6
40.5 85.0 4.0 3.3 3.3 3.6 3.6
50.3 89.2 0.7 0.9 0.9 1.0 1.0
-0.6 -0.5 3.0 2.9 2.8 3.0 3.8
31.8 67.0 0.5 0.5 0.5 0.5 0.5
11.4 21.0 1.1 1.3 2.1 1.2 1.6
36.5 73.3 0.7 0.4 0.3 0.3 0.0
51.2 94.5 1.5 1.3 1.3 1.3 1.3
24.9 50.3 1.7 1.2 1.2 1.4 1.6
34.8 73.8 1.9 1.3 1.3 1.5 1.6
6.9 16.4 0.5 0.1 0.8 0.4 0.2
7.9 22.5 0.5 1.2 0.6 0.8 0.5
40.7 77.8 1.3 1.5 1.6 1.6 1.6
1.9 3.0 0.9 0.9 0.9 1.3 1.0
5.2 10.9 1.6 0.7 1.3 0.9 1.2
9.9 30.4 1.0 1.1 0.6 0.6 0.9
36.4 85.6 2.4 2.4 2.8 3.2 3.2
36.3 75.0 1.2 1.1 1.1 1.1 1.1
35.8 74.5 1.0 0.2 0.0 0.0 0.0
45.0 92.7 2.7 3.1 3.1 3.1 3.1
38.5 80.9 0.9 0.8 0.9 1.0 1.0
45.9 84.0 2.7 3.1 3.3 3.3 3.3
38.0 84.9 3.3 3.5 3.9 3.9 3.9
3.7 9.9 1.4 0.8 0.7 0.6 0.6
46.1 76.4 3.0 1.6 0.4 0.4 0.4
14.2 28.4 0.7 0.7 0.7 0.7 1.7
48.8 91.0 1.2 1.2 1.2 1.2 1.2
18.8 38.3 1.5 0.9 1.0 0.8 1.6
21.4 42.1 2.0 1.8 1.8 1.9 2.4
30.2 68.6 1.1 1.3 1.4 1.5 1.5
36.7 82.2 2.4 1.7 0.6 0.3 0.3
                      
11.9 21.9 1.7 2.3 1.7 2.1 2.2
1.0 3.1 1.0 1.4 1.3 2.3 1.0
9.0 10.9 3.4 2.7 3.2 2.7 3.1
5.9 10.6 0.9 1.2 2.1 0.1 1.6
10.9 29.8 1.0 1.7 2.0 0.8 0.7
5.4 12.0 1.2 1.4 1.1 1.6 0.7
15.2 27.0 1.3 1.3 1.4 1.3 1.6
12.2 34.1 2.4 1.3 1.0 1.2 1.2
20.7 40.3 1.2 1.3 1.6 1.7 1.7
33.4 64.4 0.8 0.5 0.7 1.1 0.7
23.6 53.5 1.8 2.0 2.1 1.3 1.4
0.3 2.2 1.0 0.9 1.0 0.9 0.9
13.3 28.6 0.5 0.8 1.1 0.9 0.6
8.3 20.1 0.4 0.6 1.9 1.0 0.7
35.7 78.7 1.1 0.7 0.7 0.7 0.7
42.6 87.1 1.1 0.7 0.8 0.8 0.8
6.7 17.1 2.2 1.2 1.4 2.1 1.2
36.5 80.7 0.9 1.1 1.1 1.2 1.2
47.3 93.7 1.8 1.3 1.3 1.3 1.3
34.9 68.1 1.5 1.8 1.8 1.8 1.8
15.4 27.7 0.7 0.6 0.6 0.7 0.7
34.1 71.4 1.0 1.0 1.1 1.2 1.2
37.6 73.2 5.3 5.8 6.0 6.0 6.0
4.5 7.4 1.8 1.9 1.9 1.8 2.2
13.5 22.9 2.1 1.1 1.0 1.2 1.5
5.7 13.3 2.1 2.0 2.0 2.0 2.9
44.2 94.6 3.3 3.7 3.7 3.7 3.7
43.4 90.4 0.8 0.2 0.1 0.1 0.1
36.3 82.8 0.7 0.9 0.7 0.7 0.7
50.7 87.3 1.1 1.4 1.4 1.4 1.4
26.8 61.5 1.9 1.3 1.4 1.4 1.4
46.3 88.0 1.8 1.6 0.8 0.8 0.8
35.0 75.4 1.4 1.0 1.2 1.2 1.2
37.2 83.3 0.6 0.6 0.6 0.6 0.6
15.3 33.2 0.5 1.4 0.3 0.2 0.6
37.0 73.3 1.1 1.3 1.4 1.4 1.4
33.5 65.0 2.7 1.0 2.5 0.4 2.0
41.8 61.4 0.3 0.3 0.3 0.3 0.4
2.5 12.1 0.8 0.5 1.2 1.1 0.5
17.5 36.6 1.8 2.1 2.0 2.5 2.3
60.2 82.8 1.1 1.3 1.3 1.3 1.3
33.7 74.0 1.8 0.4 0.1 0.1 0.1
43.8 88.4 0.6 0.8 0.7 0.7 0.7
18.3 30.2 3.3 2.9 2.9 3.6 3.1
10.1 24.1 1.8 1.2 1.0 2.4 1.0
pH 3 0.05 pH 3 0.15 pH 3 0.30
pH 11 
0.05
pH 11 
0.15
pH 11 
0.30
Tap water 
0.05
Tap water 
0.15
Tap water 
0.30
3.4 3.1 3.6 0.4 1.4 0.5 2.9 2.4 2.2
0.7 1.3 1.1 0.8 1.0 0.8 1.8 1.3 1.3
3.8 4.0 4.0 1.9 2.0 2.0 1.3 1.3 1.6
1.1 1.8 1.3 1.8 1.8 1.8 1.4 1.2 1.1
2.5 2.7 2.9 0.6 0.4 1.4 1.4 1.8 1.7
1.6 1.2 1.3 1.2 1.2 1.5 2.8 0.6 0.1
0.1 0.1 0.1 0.8 1.6 0.3 1.7 2.0 2.1
0.5 1.5 0.2 1.8 0.9 1.3 1.0 1.1 1.9
1.9 1.7 1.7 1.5 1.1 1.3 1.2 0.8 0.9
1.4 0.6 0.5 1.3 2.3 3.2 0.7 0.8 0.5
1.0 1.3 1.3 1.8 1.0 0.1 3.2 0.2 0.2
0.5 0.5 0.5 2.1 2.2 2.3 0.7 0.7 0.8
2.3 2.0 1.2 1.4 1.7 1.9 1.1 1.7 1.2
0.5 1.2 0.9 1.5 1.4 1.5 1.5 1.2 1.5
3.1 3.8 4.0 0.5 1.3 0.2 1.7 1.7 1.6
1.7 1.5 1.5 0.9 1.9 0.8 4.5 5.0 5.9
0.5 0.4 0.0 0.7 1.9 0.4 7.1 8.5 9.5
1.2 0.9 0.9 1.5 1.3 1.3 2.5 3.5 2.0
0.0 0.0 0.0 0.6 0.2 0.7 2.5 2.1 2.2
2.2 0.7 2.0 0.8 0.6 0.6 4.1 2.8 2.8
3.4 3.5 3.5 0.7 1.5 0.8 4.0 3.2 3.4
0.9 0.9 0.9 3.9 4.1 4.4 3.8 3.4 3.8
0.4 0.3 0.3 0.7 1.7 1.5 1.3 0.7 0.7
2.4 0.4 1.3 0.2 0.2 0.3 2.3 1.0 0.8
0.4 0.4 0.4 1.6 1.5 1.8 0.4 1.5 2.2
1.3 0.9 0.9 2.6 2.6 2.7 0.3 1.9 1.1
1.4 1.4 1.4 0.2 0.4 1.3 2.1 1.4 1.3
1.0 1.2 1.7 0.7 0.2 0.2 3.6 4.4 3.4
1.0 2.1 1.3 1.0 2.3 4.9 3.4 2.2 2.2
3.1 2.8 2.8 1.6 0.9 1.1 2.5 2.1 1.6
2.6 2.8 3.5 1.7 1.2 1.2 3.1 0.7 0.5
2.7 3.1 3.1 0.8 0.5 0.6 1.2 1.5 2.8
0.5 0.5 0.5 0.7 0.8 1.1 1.8 1.8 1.8
2.3 2.3 2.3 3.1 6.4 4.1 3.9 4.2 5.0
1.9 1.9 2.4 3.0 2.0 1.8
3.5 3.7 3.7 1.0 0.3 0.5 2.5 3.1 3.1
6.0 6.2 6.2 0.6 1.0 1.2 4.6 5.3 6.2
2.1 0.9 0.6 1.1 1.5 1.4 1.1 0.7 1.4
4.0 4.3 4.3 2.8 2.8 0.9 3.5 4.3 1.1
1.3 1.1 1.2 0.6 2.0 3.8 1.4 1.3 1.3
0.3 0.8 0.2 0.1 0.9 0.3 1.1 0.4 0.4
1.6 2.1 2.2 3.0 3.7 1.1 1.5 2.1 3.5
0.8 1.0 0.6 1.3 1.3 1.3 1.7 3.0 1.5
0.9 0.8 0.8 1.7 1.8 1.7 2.4 2.2 2.4
2.1 2.1 2.1 2.8 2.4 3.0
Removal error (%) - based on duplicate analysis of each sample
2.0 2.8 3.4 0.6 1.3 1.9 2.5 2.5 2.3
1.2 1.3 1.9 1.1 0.8 0.3 2.2 1.4 1.2
3.6 3.6 3.5 2.3 1.7 1.4 1.7 1.8 1.8
0.9 1.1 1.3 0.6 1.3 1.0 3.4 3.2 3.3
0.8 0.7 1.2 0.9 1.2 0.7 0.6 0.5 1.1
0.1 1.7 2.3 0.5 1.0 0.3 0.2 0.5 1.3
2.5 2.5 2.6 2.8 0.9 0.2 2.6 2.3 2.3
1.8 2.2 2.2 1.1 1.2 0.6 0.4 1.1 0.9
1.4 1.6 1.6 1.9 1.0 1.0 0.4 1.4 1.0
1.2 0.7 0.3 0.4 0.4 0.5 1.2 0.7 1.9
1.8 2.4 1.9 1.3 1.3 0.7 1.0 1.0 0.4
1.7 2.1 0.9 0.6 0.5 0.5 2.7 2.5 2.5
1.2 1.3 1.8 1.5 1.5 1.5 0.4 0.4 0.2
0.7 1.0 1.0 3.4 3.8 3.4 1.5 2.3 2.1
2.5 3.0 4.5 2.9 3.0 3.5
0.8 0.9 1.1 0.6 0.8 0.7 1.1 1.2 1.4
1.1 1.4 1.4 1.5 1.6 1.5 2.7 1.0 0.4
0.8 1.1 1.1 1.1 1.0 1.5 2.3 2.4 3.0
0.4 0.4 0.4 2.5 2.8 2.5 3.2 3.8 4.4
2.6 2.6 2.6 1.2 1.2 1.2 1.1 1.0 1.0
0.5 0.5 0.6 1.2 1.3 1.2 2.2 0.8 0.9
1.2 0.2 0.2 0.6 1.7 1.6 3.1 4.3 3.7
0.9 0.9 0.9 2.9 2.0 2.5 2.0 3.8 1.7
1.7 0.6 0.4 1.5 2.4 1.5 1.9 1.7 2.1
1.3 0.7 1.3 1.4 1.7 1.7 2.0 2.5 1.9
1.9 2.0 2.0 1.6 1.5 1.4 0.9 0.9 0.8
0.1 0.1 0.1 4.4 3.9 3.6 4.2 5.2 5.4
1.7 1.7 1.7 3.5 3.3 3.4 2.8 1.3 1.3
0.6 1.0 0.8 0.9 0.8 0.7 1.9 2.1 1.9
2.8 3.4 2.6 3.9 1.3 1.1
1.6 1.6 1.6 0.9 1.7 0.8 4.0 3.2 3.8
1.7 1.3 1.5 1.4 0.5 0.4 2.4 1.8 2.1
1.4 1.5 1.5 2.2 2.5 2.5 0.9 1.1 1.2
2.0 2.0 2.0 2.7 3.6 2.6 0.8 1.6 1.3
1.3 0.9 1.7 2.5 2.2 2.6 1.3 0.2 0.2
0.2 0.2 0.2 0.4 0.8 0.6 3.4 0.8 0.9
0.9 0.8 0.3 1.0 1.5 0.9 1.6 1.2 2.6
0.5 0.5 0.5 1.1 0.6 0.7 0.4 0.6 0.7
2.6 3.5 1.8 1.8 2.5 1.9 1.6 1.3 1.6
1.0 0.7 0.6 1.6 1.3 1.4 1.6 1.2 1.1
5.0 6.5 6.5 3.4 1.4 2.5 6.0 7.0 7.6
2.0 2.1 2.1 2.1 2.6 2.4 3.2 3.3 3.5
1.0 1.0 1.0 2.0 0.6 1.1 3.3 1.6 2.1
1.4 1.3 0.2 1.3 0.9 2.8 1.4 0.2 3.3
1.0 0.9 1.1 1.3 0.7 0.8 1.8 0.0 0.8
Wastewater 
0.05
Wastewater 
0.15
Wastewater 
0.30
2.7 2.3 2.7
0.3 2.0 1.3
1.5 1.0 1.3
0.8 1.0 0.8
1.4 2.1 1.8
0.9 1.0 1.1
1.4 1.6 1.6
1.8 2.5 1.8
1.1 1.2 1.4
1.7 1.7 2.1
1.7 1.9 2.2
0.9 0.7 0.8
3.7 4.0 4.6
0.6 0.6 1.3
0.3 1.3 0.3
1.3 2.2 2.7
2.0 1.0 0.5
1.6 0.2 0.8
2.0 1.3 0.5
0.4 0.2 1.2
4.1 3.6 3.9
2.0 1.3 1.6
1.5 0.6 1.4
1.1 1.3 1.0
0.7 1.0 0.6
1.2 2.2 1.2
2.8 3.3 3.5
3.9 2.2 0.4
2.7 3.1 2.8
0.4 0.5 0.6
2.6 2.7 3.2
3.2 3.2 3.7
2.8 2.9 2.5
3.6 2.3 2.8
0.4 1.1 0.5
4.0 4.3 5.0
4.8 0.2 0.5
0.6 0.5 1.5
4.9 4.2 2.9
1.3 0.9 0.9
2.3 0.8 1.0
0.1 0.0 0.2
1.5 1.6 1.5
1.6 1.3 1.6
5.3 4.2 5.2
          
4.0 5.0 5.3
2.7 3.2 3.1
1.8 0.7 1.2
1.0 1.6 6.0
1.3 0.2 0.6
0.3 1.6 0.6
0.5 1.5 0.7
0.1 0.1 0.4
7.2 6.9 6.9
2.5 1.7 1.8
1.3 1.4 1.3
1.7 5.4 2.9
0.3 0.4 0.0
1.9 2.7 1.8
2.1 2.3 2.7
0.8 0.6 0.7
3.9 3.3 3.0
4.3 5.7 5.3
2.1 2.2 2.7
1.7 1.1 0.9
0.8 0.9 0.8
3.1 3.7 3.3
3.2 0.5 0.5
0.7 0.5 0.6
2.2 2.9 2.0
2.4 1.1 0.6
2.9 3.3 3.7
2.6 2.0 2.4
2.6 2.3 2.8
1.0 2.7 1.1
0.9 3.0 2.3
1.1 1.0 1.1
1.2 1.0 1.0
0.6 4.5 2.7
2.6 2.8 2.6
1.2 0.9 0.7
3.5 0.1 0.5
3.8 3.1 3.5
1.9 1.4 1.1
2.5 2.8 2.6
5.0 3.5 3.9
1.5 1.8 1.9
1.2 1.6 1.4
3.7 3.2 2.2
2.9 3.3 2.6
non-dissociated dissociated
1,7 dimethylxantine
10,11-dihydro-10-hydroxycarbamazepine
Acetaminophen 2.2E+09 1.4E+03 9.9E+08
Amphetamine
Anhydroecgonine methylester
Atenolol 8.0E+09 1.1E+02 6.3E+05
Atorvastatin 1.9E+10
Azathioprine 1.9E+09
Azithromycin 1.1E+05
Benzophenone1
Benzophenone2
Benzophenone-3 3.0E+09 3.8E+02 1.5E+06
Benzophenone4
Benzoylecgonine 5.1E+09
Bezafibrate 7.4E+09 5.9E+02
Bisphenol A 1.0E+10 1.7E+04 1.1E+09
Butylparaben 9.2E+09 4.4E+05 1.4E+09
Caffeine 5.9E+09
Carbamazepine 8.8E+09 3.0E+05
Carbamazepine 10,11-epoxide
Cetirizine 2.9E+09 6.0E+03 2.8E+05
Cimetidine 6.5E+09
Citalopram
Clarithromycin 7.0E+04
Cocaethylene
Cocaine
Codeine
Cotinine
Creatinine 2.0E+00
Desmethylcitalopram
Desvenlafaxine
Diclofenac 7.5E+09 1.0E+06
Dihydrocodeine
Dihydromorphine
Diltiazem
E1 2.6E+10 1.5E+05 4.2E+09
E2 1.4E+10 2.2E+05 3.7E+09
EDDP
EE2 1.1E+10 1.8E+05 3.7E+09
Ephedrine/pseudoephedrine
Ethylparaben 7.7E+09 3.4E+05 1.2E+09
Fexofenadine 9.0E+03 5.6E+05
Fluoxetine 9.0E+09 3.0E+00 1.7E+06
Gliclazide
Heroin
Ibuprofen 7.4E+09 9.6E+00
Ifosfamide 3.6E+09 1.0E+00
Iopromide 3.3E+09 8.0E-01
Compound
kOH (M
-1 s-1) kO3 (M
-1 s-1)
Irbesartan 2.3E+01
Ketamine
Ketoprofen 8.4E+09 4.0E-01
Lisinopril
MDA
MDMA
MDPV
Mephedrone
Metformin 1.4E+09 1.2E+00
Methadone
Methamphetamine 7.9E+09
Methotrexate 8.7E+09
Methylparaben 6.8E+09 2.5E+05 1.0E+09
Metoprolol 7.3E+09 3.3E+02 8.6E+05
Mirtazapine
Morphine 1.0E+10 6.4E+06
Naproxen 9.6E+09 2.0E+05
N-desmethyltramadol
Nicotine
Norcodeine
Norephedrine
Norfluoxetine 3.9E+00 3.5E+05
Norketamine
Normorphine
O-6-MAM
O-desmethyltramadol
Pholcodine
Propranolol 1.0E+10 1.0E+05
Propylparaben 8.6E+09 4.1E+05 1.3E+09
Quetiapine
Ranitidine 1.5E+10 2.1E+06
Sertraline
Sulfamethoxazole 5.5E+09 2.6E+06
Sulfasalazine
Tamoxifen
Temazepam
Tramadol 6.3E+09 7.7E+01 1.0E+06
Triclosan 5.4E+09 1.3E+03 5.1E+08
Trimethoprim 6.9E+09 7.4E+04 5.2E+05
Tylosin 8.2E+09 7.7E+04 2.7E+06
Valsartan
Venlafaxine 8.8E+09 7.8E+01 8.0E+05
most acidic most basic
8.5 0.2
13.8 -0.5
9.9 1.7 4.1E+06
9.9
8.0
13.9 9.4 1.7E+03
4.3 0.4
7.5
13.3 8.6 1.1E+05
7.7
7.0
7.6 6.9E+05
-0.7
3.4 10.8
3.3 -2.1 5.9E+02
10.3 1.1E+06
8.2 7.9E+07
0.5 6.7E+02
13.9 -0.5 3.0E+05
13.9 -0.5
3.5 6.7 2.8E+05
14.1 7.1
9.6
13.1 8.2 7.0E+04
9.0
9.0
13.4 8.2
4.7
6.9 2.0E+00
10.5
10.0 9.3
4.2 -2.3 1.0E+06
14.2 8.4
9.6 8.4
8.9
10.3 9.4E+05
10.3 2.2E+06
7.7
10.2 2.3E+06
14.0 9.4
8.3 5.5E+07
4.4 9.4 9.0E+03
10.1 1.6E+04
6.1 3.9
7.9
4.4 9.6E+00
1.4 1.0E+00
10.6 -2.6 8.0E-01
pKa
kO3 (M
-1 s-1) at pH 7
4.2 2.6 2.3E+01
6.5
4.2 4.0E-01
2.2 10.5
5.3
10.3
8.4
7.4
12.3 1.2E+00
9.5
10.4
3.5 5.6
8.3 4.8E+07
13.9 9.4 2.0E+03
8.1
9.5 8.3 6.4E+06
4.8 2.0E+05
14.5 10.6
8.0
13.3 9.3
12.1 8.5
9.1 6.5E+01
6.3
9.2 9.5
9.4 8.0
10.0 9.6
13.4 8.2
13.8 9.5 1.0E+05
8.2 7.0E+07
14.4 6.7
8.4 2.1E+06
9.5
5.8 1.4 2.6E+06
2.7 0.9
8.7
11.7 1.6
14.5 9.6 2.2E+03
7.8 3.8E+07
7.0 5.2E+05
13.1 7.4 5.1E+05
3.6 0.6 3.8E+01
14.8 9.3 1.3E+03
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Table S1. Molecular structure and additional information about the 90 OMPs (in alphabetical order). LC-MS performance data was obtained from 
Petrie et al. [1], where more parameters can also be found (linearity range, precision, accuracy). 
Chemical CAS number 
Molecular 
weight  
(g mol−1) 
Molecular 
formula 
Molecular structure 
Instrument 
detection limit 
(ng mL−1) 
Instrument 
quantification 
limit (ng mL−1) 
1,7 dimethylxanthine 611-59-6 180.15 C7H8N4O2 
 
0.30  1.00 
10,11 dihydro 10 
hydroxycarbamazepine 
29331-92-8 254.28 C15H14N2O2 
 
0.05  0.50  
Acetaminophen 103-90-2 151.17 C8H9NO2 
 
0.11  0.54 
Amphetamine 300-62-9 135.21 C9H13N1 
 
0.03  0.10  
Anhydroecgonine methylester 43021-26-7 181.23 C10H15NO2 
 
0.10  0.50 
Atenolol 29122-68-7 266.34 C14H22N2O3 
 
0.03  0.10 
3 
 
Atorvastatin 134523-00-5 558.64 C33H35FN2O5 
 
0.01  0.05 
Azathioprine 446-86-6 277.26 C9H7N7O2S 
 
0.03  0.10 
Azithromycin 83905-01-5 749 C38H72N2O12 
 
0.03  0.11 
Benzophenone-1 131-56-6 214.22 C13H10O3 
 
0.01  0.06 
Benzophenone-2 131-55-5 246.22 C13H10O5 
 
0.01  0.05 
Benzophenone-3 131-57-7 228.25 C14H12O3 
 
0.01  0.05 
4 
 
Benzophenone-4 4065-45-6 308.31 C14H12O6S 
 
0.31  1.01 
Benzoylecgonine 519-09-5 289.33 C16H19NO4 
 
0.01  0.05 
Bezafibrate 41859-67-0 361.83 C19H20ClNO4 
 
0.03  0.10 
Bisphenol A 80-05-7 228.29 C15H16O2 
 
0.03  0.10 
Butylparaben 94-26-8 194.23 C11H14O3 
 
0.01  0.06 
Caffeine 58-08-2 194.19 C8H10N4O2 
 
0.10  0.50 
Carbamazepine 298-46-4 236.28 C15H12N2O 
 
0.01  0.05 
5 
 
Carbamazepine 10,11 epoxide 36507-30-9 252.27 C15H12N2O2 
 
0.03  0.10  
Cetirizine 83881-51-0 388.9 C21H25ClN2O3 
 
0.02  0.08 
Cimetidine 51481-61-9 252.34 C10H16N6S 
 
0.10  0.52 
Citalopram 59729-33-8 324.4 C20H21FN2O 
 
0.05  0.50 
Clarithromycin 81103-11-9 747.97 C38H69NO13 
 
0.01  0.06 
6 
 
Cocaethylene 529-38-4 317.38 C18H23NO4 
 
0.01  0.05 
Cocaine 50-36-2 303.36 C17 H21NO4 
 
0.01  0.05 
Codeine 76-57-3 299.37 C18H21NO3 
 
0.10  0.50 
Cotinine 486-56-6 176.22 C10H12N2O 
 
0.01  0.05 
Creatinine 60-27-5 113.12 C4H7N3O 
 
0.30  1.00 
Desmethylcitalopram 62498-67-3 310.37 C19H19FN2O 
 
0.01  0.05 
7 
 
Desmethylvenlafaxine 93413-62-8 263.38 C16H25NO2 
 
0.03  0.10 
Diclofenac 15307-86-5 296.15 C14H11Cl2NO2 
 
0.03  0.10 
Dihydrocodeine 125-28-0 301.39 C18H23NO3 
 
0.03  0.10 
Dihydromorphine 509-60-4 287.36 C17H21NO3 
 
0.01  0.05 
8 
 
Diltiazem 42399-41-7 414.52 C22H26N2O4S 
 
0.01  0.05 
E1 53-16-7 270.37 C18H22O2 
 
0.10  0.49 
E2 50-28-2 272.39 C18H24O2 
 
0.09  0.47 
EDDP 30223-73-5 277.4 C20H23N 
 
0.01  0.05 
EE2 57-63-6 296.41 C20H24O2 
 
0.10  0.48 
9 
 
Ephedrine/pseudoephedrine 299-42-3 165.24 C10H15NO 
 
0.03  0.10 
Ethylparaben 120-47-8 166.18 C9H10O3 
 
0.03  0.11 
Fexofenadine 83799-24-0 501.67 C32H39NO4 
 
0.03  0.09 
Fluoxetine 54910-89-3 309.33 C17H18F3NO 
 
0.01  0.05 
Gliclazide 21187-98-4 323.41 C15H21N3O3S 
 
0.01  0.05 
Heroin 561-27-3 369.42 C21H23NO5 
 
0.10  0.50 
10 
 
Ibuprofen 15687-27-1 206.29 C13H18O2 
 
0.01  0.05 
Ifosfamide 3778-73-2 261.09 C7H15Cl2N2O2P 
 
0.01  0.05 
Iopromide 73334-07-3 791.12 C18H24I3N3O8 
 
1.16  5.79 
Irbesartan 138402-11-6 428.53 C25H28N6O 
 
0.10  0.50 
Ketamine 6740-88-1 237.73 C13H16ClNO 
 
0.01  0.05 
Ketoprofen 22071-15-4 254.29 C16H14O3 
 
0.11  0.54 
11 
 
Lisinopril 76547-98-3 405.5 C21H31N3O5 
 
0.09  0.93 
MDA 4764-17-4 179.22 C10H13NO2 
 
0.03  0.10 
MDMA 42542-10-9 193.25 C11H15NO2 
 
0.01  0.05 
MDPV 687603-66-3 275.34 C16H21NO3 
 
0.01  0.50 
Mephedrone 1189805-46-6 177.24 C11H15NO 
 
0.01  0.05 
Metformin 657-24-9 129.17 C4H11N5 
 
0.09  0.43 
12 
 
Methadone 76-99-3 309.46 C21H27NO 
 
0.11  0.56 
Methamphetamine 537-46-2 149.24 C10H15N 
 
0.03  0.10 
Methotrexate 59-05-2 454.45 C20H22N8O5 
 
0.28  0.92 
Methylparaben 99-76-3 152.15 C8H8O3 
 
0.01  0.06 
Metoprolol 51384-51-1 267.37 C15H25NO3 
 
0.01  0.05 
Mirtazapine 85650-52-8 265.35 C17H19N3 
 
0.01  0.05 
13 
 
Morphine 57-27-2 285.35 C17H19NO3 
 
0.30  1.00 
Naproxen 22204-53-1 230.27 C14H14O3 
 
0.10  0.49 
N-desmethyltramadol 75377-45-6 249.35 C15H23NO2 
 
0.01  0.05 
Nicotine 54-11-5 162.24 C10H14N2 
 
0.30  1.00 
Norcodeine 467-15-2 285.35 C17H19NO3 
 
0.30  1.00 
Norephedrine 492-39-7 151.21 C9H13NO 
 
0.01  0.50 
14 
 
Norfluoxetine 83891-03-6 295.3 C16H16F3NO 
 
0.01  0.05 
Norketamine 35211-10-0 233.7 C15H11ClN2O 
 
0.03  0.10 
Normorphine 466-97-7 271.32 C16H17NO3 
 
0.30  1.00 
O-6-MAM 2784-73-8 327.37 C19H21NO4 
 
0.03  0.10 
O-desmethyltramadol 185453-02-5 249.35 C15H23NO2 
 
0.01  1.00 
15 
 
Pholcodine 509-67-1 398.51 C23H30N2O4 
 
0.35  1.14 
Propranolol 525-66-6 259.35 C16H21NO2 
 
0.03  0.09 
Propylparaben 94-13-3 180.21 C10H12O3 
 
0.04  0.12 
Quetiapine 111974-69-7 384.52 C21H25N3O2S 
 
0.01  0.05 
Ranitidine 66357-35-5 314.41 C13H22N4O3S 
 
1.03  5.17 
Sertraline 79617-96-2 306.24 C17H17Cl2N 
 
0.01  0.05 
16 
 
Sulfamethoxazole 723-46-6 253.28 C10H11N3O3S 
 
0.03  0.10 
Sulfasalazine 599-79-1 398.4 C18H14N4O5S 
 
0.27  0.90 
Tamoxifen 10540-29-1 371.53 C26H29NO 
 
0.01  0.03 
Temazepam 846-50-4 300.75 C16H13ClN2O2 
 
0.01  0.05 
Tramadol 27203-92-5 263.38 C16H25NO2 
 
0.01  1.00 
17 
 
Triclosan 3380-34-5 289.55 C12H7Cl3O2 
 
0.34  1.13 
Trimethoprim 738-70-5 290.32 C14H18N4O3 
 
0.03  0.10 
Tylosin 1401-69-0 916.12 C46H77NO17 
 
0.01  0.10 
Valsartan 137862-53-4 435.53 C24H29N5O3 
 
0.34  1.12 
Venlafaxine 93413-69-5 277.41 C17H27N1O2 
 
0.01  0.04 
 
18 
 
Table S2. Second order rate constants for the reaction of 40 OMPs with OH radicals. 
Experimentally determined, unless otherwise specified (QSAR: Quantitative structure–activity 
relationship). 
Compound kOH (M−1 s−1) Reference 
Acetaminophen 2.2×109 [2] 
Atenolol 8.0×109 [3] 
Atorvastatin 1.9×1010 [4] 
Azathioprine 1.86×109 [5] 
Azithromycin 2.9×109 [6] 
Benzophenone-3 2.97×1010 [7] 
Benzoylecgonine 5.13×109 [8] 
Bezafibrate 7.4×109 [9] 
Bisphenol A 1.02×1010 [10] 
Butylparaben 9.2×109 [11] 
Caffeine 5.9×109 [12] 
Carbamazepine 8.8×109 [9] 
Cimetidine 6.5×109 [13] 
Diclofenac 7.5×109 [9] 
E1 2.6×1010 [14] 
E2 1.41×1010 [10] 
EE2 1.08×1010 [10] 
Ethylparaben 7.7×109 [11] 
Fluoxetine 9×109 [15] 
Ibuprofen 7.4×109 [9] 
Ifosfamide 3.6×109 [16]  
Iopromide 3.3×109 [9] 
Ketoprofen 8.4×109 [17] 
Metformin 1.4×109 [16] 
Methamphetamine 7.9×109 [18] 
Methotrexate 8.7×109 [19] 
Methylparaben 6.8×109 [11] 
Metoprolol 7.3×109 [3] 
Morphine 1010 (QSAR) [20] 
Naproxen 9.6×109 [21] 
Propranolol 1.0×1010 [3] 
Propylparaben 8.6×109 [11] 
Ranitidine 1.5×1010 [13] 
Sulfamethoxazole 5.5×109 [9] 
Tramadol 6.3×109 [22] 
Triclosan 5.4×109 [23] 
Trimethoprim 6.9×109 [6] 
Tylosin 8.2×109 [6] 
Valsartan 1010 (QSAR) [20] 
Venlafaxine 8.8×109 [16] 
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